Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
UK regulator approves second Alzheimer's drug in months but government won't pay for it
Britain’s drug regulator approved the Alzheimer’s drug Kisunla on Wednesday, but the government won’t be paying for it after an independent watchdog agency said the treatment isn’t worth the cost to t
UK approves Lilly's Alzheimer's drug, but deemed 'too expensive' for wide use
Eli Lilly's treatment for early Alzheimer's was deemed too expensive for wide use by UK's cost-effectiveness body on Wednesday, signalling that patients are unlikely to get access following approval by the country's medicines regulator.
Eli Lilly’s Alzheimer’s drug donanemab rejected for NHS use
Alzheimer’s drug donanemab for use in the country's national health service (NHS). The National Institute for Health and Care Excellence (NICE), which sets drug policy for the NHS, issued a draft guidance on Wednesday,
4h
on MSN
Neuroscientists Reveal New Alzheimer's 'Brain Maintenance' Skill
Researchers have used advanced brain-imaging techniques to determine whether language skills physically alters the brain's ...
2h
on MSN
'Alzheimer's drugs will come too late for us'
A couple from Hull have called on the government to fund new Alzheimer's drugs, even though they say it will come "too late" ...
5h
What Drugmakers Did Not Tell Volunteers in Alzheimer’s Trials
Genetic tests showed that certain patients were predisposed to brain injuries if they took the drugs. That information ...
6h
on MSN
England’s Drug-Cost Watchdog Rejects Eli Lilly’s Alzheimer’s Drug
England’s drug-cost regulator rejected Eli Lilly’s Alzheimer’s drug for use in the country’s public health system, marking ...
4h
New Alzheimer’s drugs should be available on NHS, says patient’s wife
A wife whose husband will not be eligible for new Alzheimer’s drugs has implored health leaders to ensure that others like ...
NOLA.com
2d
Posterial Cortical Atrophy could be wake-up call about future development of Alzheimer's
Posterial Cortical Atrophy, sometimes called Benson’s disease, is a rare degenerative brain condition that affects the back ...
10h
on MSN
Alzheimer’s wonder drug faces NHS block over cost
The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare ...
10h
Eli Lilly Alzheimer’s Drug Rejected for NHS Use in England
Eli Lilly & Co’s Alzheimer’s drug won’t be made available for patients using England’s National Health Service, after the ...
FOX 13 Seattle on MSN
13h
Alzheimer's study in Seattle makes new findings for future therapies
In the heart of Seattle, some of the world’s most brilliant minds study the brain at the Allen Institute, where researchers ...
NBC News
13h
Barbara Corcoran shares her experience caring for her mother with Alzheimer’s
Real estate mogul Barbara Corcoran opened up to NBC
News
’ Christine Romans about her experience caring for her mother who was living with
Alzheimer
’s disease for nine years. The “Shark Tank” star ...
7h
BBC News - 12:00 Alzheimer's drug, Manchester bombing case, water review - BBC Sounds
The latest news from the BBC.
19h
Clinical trials sparking hope for Alzheimer's patients: ‘Holding my own'
A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
NHS
Eli Lilly
National Health Service
Feedback